Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson's disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkineti...

Chorea, hemichorea, hemiballismus and other parkinsonian movement disorders have been described in type 1 diabetic patient with uncontrolled hyperglycemia. In comparison, abnormal movements in diabetic ketoacidosis are rare though ketosis due to other causes can cause parkinsonism-like movement disorders. We report two cases of diabetic ketoacidosis where hemifacial spasm was the predominant cl...

objective(s): the main characteristic of mesenchymal stem cells (mscs) is their ability to produce other cell types. electromagnetic field (emf) stimulates differentiation of mscs into other cells. in this study, we investigated whether emf can effect on the differentiation of mscs into dopaminergic (da) neurons. materials and methods: an emf with a frequency of 50 hz and two intensities of 40 ...

Involuntary movements (dyskinesia) are a common symptom of dopamine-replacement therapy in parkinsonian patients, neuroleptic drug treatment of mental patients, and tic disorders. Levodopa-induced dyskinesia has been shown to be associated with substantial reduction of firing rate in the internal part of the globus pallidus. This study characterizes the changes that occur in the activity of the...

High-frequency stimulation of the subthalamic nucleus (STN) constitutes one of the most effective treatments for advanced forms of Parkinson's disease. The cost and potential risks of this procedure encourage the determination of clinical characteristics of patients that will have the best postoperative outcome. Forty-one Parkinson's disease patients underwent surgery for bilateral STN stimulat...

OBJECTIVE Differentiating idiopathic Parkinson's disease from atypical parkinsonian syndromes is challenging, especially in the early stages. We assessed whether the Revised Addenbrooke's Cognitive Examination (ACE-R) could differentiate between parkinsonian syndromes and reflect longitudinal changes in cognition in these disorders. METHODS The ACE-R was administered at baseline and after app...

Nevet, Alon, Genela Morris, Guy Saban, Nina Fainstein, and Hagai Bergman. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphineinduced orofacial dyskinesia. J Neurophysiol 92: 1973–1981, 2004. First published April 28, 2004; 10.1152/jn.01036.2003. Involuntary movements (dyskinesia) are a common symptom of dopamine-replacement therapy ...